Shares of biotech-related companies are trading higher after reports suggesting that President Trump has appointed Kyle Diamantas as Acting FDA Commissioner, replacing Dr. Marty Makary.

Benzinga Newsdesk www.benzinga.com Positive 73.1%

Neg 0% Neu 0% Pos 73.1%

Comments

No comments yet. Be the first!